Gene	Type	Source	Treatment	Cancer Type	DOID	Level	Direction
ERBB2	Amplification	CIViC	Trastuzumab	Breast Cancer	X	A	Responsive
ERBB2	Amplification	CIViC	Panitumumab	Colorectal Cancer	X	B	Resistant
MET	Amplification	iClusion	DRUP	Solid Tumors	X	B	Responsive
NRAS	Activation	CGI	Cetuximab	Colorectal Cancer	X	A	Resistant
BRCA1	Inactivation	iClusion	DRUP	Solid Tumors	X	B	Responsive
FGFR2	Fusion Five	OncoKB	Erdafitinib	Bladder Cancer	X	B	Responsive
ALK	Fusion Three	CGI	Crizotinib	Lung Adenocarcinoma	X	A	Responsive